BlackRock Japan’s Fortress Biotech FBIO Stock Holding History

BlackRock Japan’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-33	Closed	-$1K	–	1440
2015 Q4	$1K	Buy	+33	New	+$1.38K	﹤0.01%	1385

Other funds holding FBIO

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BGA

Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

BlackRock Japan's FBIO Position: Q1 2016 in Review

BlackRock Japan sold out of Fortress Biotech (FBIO) in Q1 2016, closing a stake of 33 shares — an estimated $1K sold.

BlackRock Japan first reported a position in FBIO in Q4 2015 and held it in 1 quarter. The position peaked at $1K in Q4 2015. 44 funds tracked by Wall St. Rank hold FBIO as of Q1 2016.

BlackRock Japan reported no remaining Fortress Biotech position as of Q1 2016 after selling out during the quarter.
BlackRock Japan sold 33 Fortress Biotech shares in Q1 2016, an estimated $1K.
BlackRock Japan first reported a position in Fortress Biotech in Q4 2015 and held it in 1 quarter.
BlackRock Japan's Fortress Biotech position peaked at $1K in Q4 2015.
44 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2016.

Based on BlackRock Japan's 13F filing for Q1 2016, filed 10 May 2016.